Compare YDES & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | YDES | ISD |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.8M | 390.1M |
| IPO Year | 2024 | N/A |
| Metric | YDES | ISD |
|---|---|---|
| Price | $5.85 | $11.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 380.9K | 165.0K |
| Earning Date | 08-31-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $11.40 |
| 52 Week High | $18.57 | $14.79 |
| Indicator | YDES | ISD |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 36.05 |
| Support Level | $4.97 | $11.46 |
| Resistance Level | $8.89 | $11.76 |
| Average True Range (ATR) | 1.01 | 0.14 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 20.43 | 17.76 |
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.